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1. INTRODUCTION 
1.1. GASTRO-ESOPHAGEAL REFLUX DISEASE 
Repeated regurgitation of the gastric/duodenal content to the esophagus may 
lead to gastro-esophageal reflux disease (GERD) which is responsible for a high 
proportion of dyspeptic/digestive symptoms in the European population. 
The leading symptoms are heartburn, retrosternal pain, dysphagia or 
odynophagia. Several mechanisms are involved in the pathogenesis including lower 
esophageal sphincter (LES) incompetency, decreased esophageal clearance, weak 
esophagus body motility, abnormal gastric emptying, hiatal hernia, medications that 
weaken LES, anticholinerg drugs, calcium-channel blocking agents. Prolonged 
regurgitation of the stomach or duodenal content can lead to different complications, 
such as esophagitis, ulcer, stricture, and Barrett's esophagus, which is predisposed 
to malignancy. Barrett's metaplasia develops when the normal squamous epithelium 
is replaced by a columnar-lined, metaplastic epithelium, and this condition occurs in 
15% to 20% of GERD patients (DeMeester et al, 2000, Hirota et at., 1999). The 
prevalence of adenocarcinoma of the esophagus and esophagogastric junction is 
increasing at an extraordinary rate (Devesa eta!., 1998). 
In the last decades GERD became the most frequent inflammatory disease of 
the foregut in the Western world (Gallup 1988). The diagnostic tools for appropriate 
diagnosis are esophageal endoscopy and biopsy, manometry, 24 hours pH-metry, 
and optionally X-ray and/or Bilitec examination. 
1.2. PATHOPHYSIOLOGY OF REFLUX ESOPHAGITIS 
Although the pathogenesis has been extensively studied, the primary cause of 
the mucosal barrier damage leading to the clinico-pathologic complications in the 
affected patients is still unknown. The importance of gastric acid in the progression of 
GERD is well-known, but the significance of other components of the refluxed 
material is still controversial. Most studies have found an apparent association 
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between gastric acid reflux and esophageal inflammation (Vaezi et al., 1996). In 
particular, regurgitated bile can often be detected in the esophagus, and is assumed 
to trigger the development of Barrett's metaplasia and esophageal adenocarcinoma 
(Attwood et al., 1989, Miwa et al., 1996). However, esophagitis is a frequent finding 
in GERD patients with acid-suppressive therapy or even after total gastrectomy. 
Similarly, it has been shown that bile-induced mucosal changes per se may 
contribute significantly to esophageal barrier lesions and the development of GERD 
(Bremner et al., 1993). 
Although the exact pathomechanism of GERD is not fully understood, several 
lines of indirect evidence suggest that a mitochondrial dysfunction may play a role in 
the reflux-induced esophageal mucosal responses. The hepatic mitochondria are one 
of the main targets of bile-induced hepatocyte damage, and the intracellular 
accumulation of hydrophobic bile salts during cholestasis causes hepatocyte 
necrosis by inducing a mitochondrial permeability transition (Spievy et al., 1993, 
Gores et al., 1998). However, the in vivo effects of intraluminal bile exposure on the 
mitochondrial functions of the esophagus are still unclear. 
Similarly, the available clinical and experimental evidence suggests that 
microvascular injury is a causative factor in secondary detrimental reactions, 
including permeability changes and bacterial or endotoxin translocation in the 
gastrointestinal tract (Chen etal., 1996, Alican etal., 1996). Nevertheless, the in vivo 
response of the esophageal microcirculation to acute regurgitation has not been 
studied. 
1.3. AIMS 
Our first goal was to create a large animal model of acute gastroesophageal 
reflux, where the effects of different components of the refluxed material could be 
observed separately. Our second aim was to obtain an insight into the initial 
processes leading to tissue injury during GERD. We hypothesized that mitochondrial 
dysfunction may be directly associated with secondary functional and structural 
changes in the esophageal mucosa. Accordingly, the consequences of exposure to 
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bile with or without gastric acid, as possible luminal damaging agents, were 
characterized separately in our large animal model of acute GERD. In line with this 
goal, bile-induced morphological changes were also evaluated and compared with 
acid-caused structural damage. 
Our next objective was to characterize the reactive microcirculatory changes in 
the esophageal mucosa during acute esophageal regurgitation. To this end, the 
mucosal microcirculatory changes were observed continuously by means of intravital 
videomicroscopy after a standardized biliary, acidic, or mixed challenge. 
A further aim was to outline those elements which may be linked to 
microcirculatory alterations and could participate in the evolving mucosal dysfunction. 
Nitric oxide (NO) plays a central role in the maintenance of the normal resting 
esophageal mucosal blood flow (McKie et al., 1995, Sandler et al., 1993), and it has 
been suggested that local changes in NO release may be critically involved in 
gastrointestinal inflammatory reactions (Salzman et al., 1995). Hence, our last 
objective was to determine the consequences of acute reflux on the activities of the 
constitutive NO synthase (cNOS) and inducible NOS (iNOS) isoforms. 
In the first series (Study I) we investigated the role of different reflux 
components (bile, bile + acid, and acid alone) in the mitochondrial energy turnover 
changes, permeability and morphological alterations on esophageal mucosa during 
acute reflux esophagitis. 
In the second series of experiments (Study II) esophageal microcirculatory 
changes and changes in mucosal cNOS and iNOS activities were evaluated. 
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2. MATERIALS AND METHODS 
The experiments were performed in adherence to the NIH guidelines for the 
use of experimental animals. The study was approved by the Ethical Committee for 
the Protection of Animals in Scientific Research at the University of Szeged. 
2.1. SURGICAL PREPARATION 
The surgical interventions were almost identical in Studies I and II. The 
experiments were performed on a total of 54 mongrel dogs (average weight 15.5±2 
kg) under sodium pentobarbital anesthesia (30 mg kg'1 ¡.v.). Small supplementary 
doses of pentobarbital were administered when necessary. The animals were placed 
in a supine position on a heating pad for the maintenance of body temperature 
between 37 and 38 °C. In aseptic techniques, the left femoral artery and vein were 
cannulated for the measurement of mean arterial pressure (MAP) and for fluid and 
drug administration, respectively. All animals received a continuous infusion of 
Ringer's lactate at a rate of 10 ml kg"1 h"1 during the experiments. The esophagus 
was inspected by endoscopy (Olympus GIF-E) prior to the experiments to exclude 
major mucosal lesions. Following a collar incision, a part of the cervical esophagus 
with intact neurovascular connections was dissected free, and an approximately 8-
10-cm segment of the middle portion was then occluded at both ends with atraumatic 
clips. A plastic tube (0.5 mm i.d.) was inserted distally into the lumen and secured 
with a purse-string suture for the administration of test compounds. In Study I an agar 
electrode was placed surgically into the esophageal lumen for continuous 
measurement of the transmucosal potential difference. In Study II the objective of the 
intravital microscopic device was introduced into the middle portion of the prepared 
esophageal segment through a small incision. 
8 
2.2. EXPERIMENTAL PROTOCOLS 
2.2.1. STUDY I. 
Surgery was followed by a 20-min recovery period for cardiovascular 
stabilization, then 7 ml of isotonic saline (pH 7.4) was injected into the lumen of the 
prepared esophageal segment. Baseline variables were recorded for 30 min, then 
the esophagus segment was filled with test solution (7 ml) for 4 hours. At the and of 
the 3rd hour of the experiment sodium fluorescein (NaFI) was added into the 
intraluminal content and 30 min later Evans blue dye was injected i.v. At the end of 
the experiment, a biopsy was taken from the esophageal segment, together with a 
tissue sample from the aboral, intact part of the esophagus, with the freeze-clamp 
technique, for determination of the tissue adenosine triphosphate (ATP) 
concentrations. Additional biopsies were obtained for measurement of the tissue 
myeloperoxidase (MPO) activity and the vascular permeability index, and 
establishment of the severity of tissue damage. 
The animals were randomized to one or other of the following groups: group 1 
(n=8): saline-treated (pH 7.4) control, group 2 (n=8): bile-treated (pH 6.5), group 3 
(n=5): hydrochloric acid (HCI) + bile-treated (pH 2.5), and group 4 (n=5): HCI-treated 
(pH 2.0). Canine bile was obtained from 3 healthy dogs before the experiments, 
pooled and stored at -20 °C. The intraluminal volume load was identical in all groups 
studied. 
2.2.2. SUDY II. 
Surgery was followed by a 20-min recovery period for cardiovascular 
stabilization, and 7 ml isotonic saline (pH 7.4) was then introduced into the 
esophageal segment for 30 min to determine the baseline microcirculatory 
parameters. After this period, the esophagus was filled with different test solutions (7 
ml) for 3 hours, meanwhile the microcirculatory parameters continuously were 
observed. At the end of the experiments full-thickness biopsies were taken from the 
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esophagus for histology, and NOS and myeloperoxidase (MPO) activity 
measurements. 
The animals were randomly allocated into 4 groups. Group 1 (n=5) received 
0.9% saline (pH 7.4), group 2 (n=8) canine bile (pH 6.5), group 3 (n=8) HCI (pH 2.0), 
and group 4 (n=7) bile + HCI solution (pH 2.5). 
2.3. MEASUREMENTS 
Central venous pressure and mean arterial pressure were measured 
continuously with Statham P23Db transducers and registered with a computerized 
data-acquisition system (Haemosys 1.17; Experimetria Ltd., Budapest, Hungary). 
Arterial blood gases were measured with an AVL Compact 2 blood gas analyzer 
(AVL, Graz, Austria). 
2.3.1. TRANSMUCOSAL POTENTIAL DIFFERENCE 
An exploring electrode was inserted into the lumen of the esophagus, and the 
reference electrode was placed into the paraesophageal space. The electrodes were 
filled with 3% agar solution dissolved in saturated potassium chloride solution. The 
agar bridges were connected to a calomel electrode (Radelkis, Budapest, Hungary) 
and a potentiometer, and the transmucosal potential difference changes (in mV) were 
recorded on a continuously running polygraph. 
2.3.2. EPITHELIAL PERMEABILITY INDEX 
180 min after the insult, lumen-to-blood directional epithelial permeability 
changes were detected by the NaFI clearance method (Szabo A et al., 1997). Briefly, 
40 mg of NaFI (MW 376, Sigma Chemicals, 5 mg ml"1) was added into the 
esophageal lumen. Blood samples were taken from the femoral vein in 10-min 
periods, and the NaFI concentration of the plasma was determined. The blood 
samples (2 ml) were collected in prechilled tubes containing 250 IU heparin, and 
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immediately centrifuged at 1000 g at 4 °C for 5 min. The samples were stored at 0 °C 
in the dark for a maximum of 120 min. NaFI concentrations were measured with an F-
2000 Hitachi fluorescence spectrophotometer (ex: 455 nm, em: 515 nm). The lumen-
to-plasma clearance of NaFI was calculated according to the following equation: 
inward NaFI clearance = [NaFI concentrationjserum x 100 / [NaFI concentrationjtest 
solution x volume. 
2.3.3. VASCULAR PERMEABILITY INDEX 
The vascular permeability index was determined by using the azo dye Evans 
blue (Sigma Chemicals), which binds rapidly to albumin and migrates with it (Arkovitz 
et ai, 1996). At 210 min in the experiments, 20 mg Evans blue ml"1 kg"1 was given i.v. 
in a bolus injection, and 30 min later a blood sample was taken from the femoral vein, 
together with tissue samples from the intact and the exposed sections of the 
esophagus. The mucosal layer was scraped off, rapidly placed in 5 ml of formamide, 
and homogenized for 1 min in a glass Potter homogenizer. The homogenate was 
incubated at room temperature for 20 hours and then centrifuged at 2500 g for 30 
min. The absorbance of the supernatant was determined at 650 nm against a 
formamide blank with a UV-1601 spectrophotometer (Shimadzu, Japan). The 
concentration of Evans blue was determined from a standard curve. The protein 
contents of the samples were determined by the procedure of Lowry et al (1951). 
Similarly, blood samples were centrifuged at 600 g at 4 °C for 10 min and the 
absorbance of the 100-fold-diluted plasma was measured. Vascular permeability 
index was defined as the ratio of the tissue and plasma concentrations of Evans blue: 
Vascular permeability index=[Evans blue concentrationjtissue / [Evans blue 
concentrationjplasma x 100. 
2.3.4. MYELOPEROXIDASE ENZYME ACTIVITY 
The mucosal tissue MPO activity, as a marker of tissue leukocyte infiltration, 
was measured from mucosal biopsies by the method of Kuebler (Kuebler et al., 
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1996). Briefly, the tissue was homogenized with Tris-HCI buffer (0.1 M, pH 7.4) 
containing 0.1 mM polymethylsulfonyl fluoride to block tissue proteases, and then 
centrifuged at 4 °C for 20 min at 2000 g. The MPO activities of the samples were 
measured at 450 nm (UV-1601 spectrophotometer, Shimadzu, Japan), and the data 
were referred to the protein content. 
2.3.5. ATP MEASUREMENT 
A whole-thickness sample was taken from the esophagus with a Wollenberg 
forceps cooled in liquid nitrogen, and the tissue was stored at -70 °C. The sample 
was weighed, placed into a 3-fold volume of trichloroacetic acid (6% w/v), 
homogenized for 1 min, and centrifuged at 5000 g. The supernatant was neutralized 
with saturated potassium carbonate solution. The ATP concentration was measured 
spectrophotometrically according to Lamprech et al. (1976). The method is based on 
the principle that beta-nicotinamide adenine dinucleotide phosphate is used up in an 
enzymatic reaction catalyzed by glucose-6-phosphate dehydrogenase and 
hexokinase. 
2.3.6. HISTOLOGY AND LIGHT MICROSCOPY 
Biopsies for light microscopy were obtained from the intact and the treated 
parts of the esophagus of each animal. The samples were fixed in 10% phosphate-
buffered formalin solution for 24 h, embedded in paraffin, sectioned (6 pm) and 
stained with hematoxylin-eosin. Histological analysis was performed in coded 
sections by one investigator. Mucosal injury was graded on the 0-100 esophageal 
mucosal damage score of Lanas et al. (1999) with the following criteria: epithelial 
changes (epithelial splitting, erosion and ulceration): maximal score 40; inflammation 
(intraepithelial leukocytes and cellular hyperplasia): maximal score 40; vascular 
lesions (edema, congestion and hemorrhage): maximal score 20. In Study II in 
parallel, the degree of damage was evaluated with the 0-16 scoring system of 
Geisinger et al. (1990): basal cell hyperplasia: maximal score 4; intraepithelial 
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leukocytes: maximal score 4; subepithelial leukocytes: maximal score 4; presence of 
ulceration: maximal score 4. 
2.3.7. INTRAVITAL VIDEOMICROSCOPY 
An intravital videomicroscope was used with an orthogonal polarization 
spectral imaging (OPS) technique (Cytoscan A/R, Cytometrics, PA, USA) to monitor 
microvascular perfusion changes in the esophageal mucosa. The OPS technique 
involves the use of reflected polarized light at 548 nm, which is the isosbestic point of 
oxy- and deoxyhemoglobin. Since polarization is preserved in reflection, only photons 
scattered from relatively deep inside the tissue contribute to the images. In this way, 
a virtual light source is created in the tissues, so that the vessels appear black 
(Groner et al., 1999). A 10x objective was connected to a light source with a flexible 
cable; in this way, the esophageal segment was not exteriorized during the study. 
Quantitative assessment of the microcirculatory parameters was performed off-line 
by frame-to-frame analysis of the videotaped images. The functional capillary density 
(FCD; the length of perfused nutritive capillaries per observation area; pm"1), the 
relative vessel area (RVA; the perfused vessel area per observation area), and the 
red blood cell velocity (RBCV; pm sec"1) were determined in 3 separate fields by 
means of a computer-assisted image analysis system (IVM Pictron®, Budapest, 
Hungary). All data were expressed as the means of 3 measurements at each time 
point. 
2.3.8. NITRIC OXIDE ENZYME ACTIVITY MEASUREMENTS 
Nitric oxide (NO) formation in esophageal tissues was measured by the 
conversion of (3H)L-citrulline from (3H)L-arginine according to the method of Szabo et 
al. (1993). Briefly, tissue biopsies kept on ice were homogenized in phosphate buffer 
(pH 7.4) containing 50 mM tris-(hydroxymethyl)-aminomethane-HCI (Reanal, 
Budapest, Hungary), 0.1 mM ethylenediaminetetraacetic acid (Serva Feinbiochemica 
GmbH, Heidelberg, Germany), 0.5 mM dithiotreitol, 1 mM phenylmethylsulfonyl 
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fluoride and 10 pg ml'1 soybean trypsin inhibitor. The homogenate was centrifuged at 
4 °C for 20 min at 24000 g and the supernatant was loaded into centrifugal 
concentrator tubes (Amicon Centricon-100; 100 000 MW cut-off ultrafilter). The tubes 
were centrifuged at 1000 g for 150 min and the concentrated supernatant was 
washed out from the ultrafilter with 300 pi homogenizing buffer. The samples were 
incubated with a cation-exchange resin (DOWEX AG 50W-X8, Na+ form) for 5 min to 
deplete endogenous L-arginine. The resin was separated by centrifugation (1500 g 
for 10 min) and the supernatant containing the enzyme was assayed for NOS 
activity. 
For the Ca2+-dependent NOS (cNOS) activity, 50 pi enzyme extract and 100 pi 
reaction mixture (pH 7.4, containing 50 mM Tris-HCI buffer, 1 mM NADPH, 10 pM 
tetrahydrobiopterin, 1.5 mM CaCb, 100 U ml"1 calmodulin and 0.5 pCi (3H)L-arginine 
(ICN Biomedicals, specific activity 39 Ci mmol'1) were incubated together for 30 min 
at 37 °C The reaction was stopped by the addition of 1 ml ice-cold HEPES buffer (pH 
5.5) containing 2 mM EGTA and 2 mM EDTA. Measurements were performed with 
boiled enzyme and with the NOS inhibitor N-w-nitro-L-arginine (3.2 mM) to determine 
the extent of (3H)L-citrulline formation independent of the NOS activity. Ca2+-
independent NOS activity (iNOS) was measured without Ca-calmodulin and with 
EGTA (8 mM). 
1 ml reaction mixture was applied to DOWEX cation-exchange resin (AG 50W-
X8, Na+ form) and eluted with 2 ml distilled water. The eluted (3H)L-citrulline activity 
was measured with a scintillation counter (Tri-Carb Liquid Scintillation Analyzer 
2100TR/2300TR, Packard Instrument Co, Meriden, CT, U.S.A.). Protein contents of 
samples were determined by the method of Lowry et al. (1951). 
2.3.9. STATISTICAL ANALYSIS 
Data analysis was performed with a statistical software package (SigmaStat 
for Windows, Jandel Scientific, Erkrath, Germany). Nonparametric methods were 
used. Friedman repeated measures analysis of variance on ranks was applied within 
the groups. Time-dependent differences from the baseline were assessed by Dunn's 
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method. Differences between groups were analyzed with Kruskal-Wallis one-way 
analysis of variance on ranks, followed by Dunn's method for pairwise multiple 
comparison. In the Figures, median values and 75th and 25th percentiles are given, p 
values <0.05 were considered significant. 
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3. RESULTS 
3.1. STUDY I 
The baseline values of the macrohemodynamic variables did not differ 
significantly in the different groups and there were no significant hemodynamic 
changes as compared with the baseline values during the experimental period (data 
not shown). In the control group, saline administration did not significantly influence 
the mucosal morphology as compared with that observed in the untreated part of the 
esophagus. In this group, the baseline mucosal permeability, the transmucosal 
potential difference, the ATP level and the intramucosal leukocyte accumulation 
remained essentially constant throughout the observation period. 
Intraluminal bile resulted in an approximately 60% decrease in transmucosal 
potential defference (M=29.5%; 25p=18.8%; 75p=31.9%), and in significant 
increases in the vascular permeability index (M=0.953; 25p=0.84; 75p=1.05) and 
transmucosal NaFI clearance (M=4.54; 25p=4.1; 75p=5.01) (Figs 1-3). 
Transmucosal potential difference 
(changes relative to the baseline, %) 
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Figure 1. Changes in transmucosal potential 
difference between intra- and extraluminal 
esophageal spaces. Thin line with empty 
circles: saline-treated control, thick line with 
filled squares: bile-treated group, broken line 
with empty triangles: HCI + bile-treated 
group, broken line with filled triangles: HCI-
treated group. * p< 0.05 vs. baseline, * 
p<0.05 vs. saline-treated control group. 
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Similar changes were observed in the bile + HCI-treated group: transmucosal 
potential difference was significantly decreased, with parallel increases in vascular 
permeability index and NaFI clearance (Figs 1-3). 
HCI alone induced a decrease in transmucosal potential difference and an 
increase in the lumen-to-blood direction mucosal permeability, similar to those 
observed following bile and bile + HCI administration. However, the change in 
vascular permeability index remained statistically nonsignificant throughout the 
experiments (Figs 1-3). 
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Figure 2. Vascular permeability index in the 
intact and treated regions of the esophagus 
at 240 min in the experiments. Saline-treated 
control group: white box, bile-treated group: 
black box, HCI - bile-treated group: gray box, 
HCI-treated group: hatched box. * p< 0.05 vs. 
baseline, x p<0.05 vs. saline-treated group. 
. 1 4 Plasma-Na fluorescein/lumen-Na fluorescein kg x 10 
1 0 -
0 -
200 210 220 
Time (min) 
Figure 3. Changes in epithelial permeability 
index (Na-fluorescein clearance) during the 
last 60 min of the experiments. Saline-treated 
control group: thin line with empty circles, 
bile-treated group: thick line with empty 
squares, HCI+bile-treated group: broken line 
with empty triangles, HCI-treated group: 
broken line with filled triangles. * p< 0.05 vs. 
baseline,x p<0.05 vs. saline-treated group. 
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The leukocyte accumulation was significantly increased in the mucosa in 
groups 2, 3 and 4 as compared with the intact part of the esophagus, or with the 
saline-treated group 1. Bile, bile + HCL, or HCI administration alone resulted in a 6-
fold (M=18.1; 25p=15.7; 75p=22.6), an 8-fold (M=24.6; 25p=20.4; 75p=27.8) and a 
2.5-fold (M=6.65; 25p=4.9; 75p=8,05) increase in myeloperoxidase activity, 
respectively (Fig. 4). 
40 
30 
20 
10 
m i l m g 1 p r o t e i n min 1 
Sal ine 
• M Bile 
SBBSB HCI+bile 
EZZZJ HCI 
Figure 4. Myeloperoxidase activity in the 
intact and treated parts of the mucosa of the 
esophagus at 240 min in the experiment. 
Saline-treated control group: white box, bile-
treated group: black box, HCI + bile-treated 
group: gray box, HCI-treated group: hatched 
box. * p< 0.05 vs. baseline, x p<0.05 vs. 
saline-treated control group. 
Intact region of 
the esophagus 
Treated region of 
the esophagus 
Data on the esophageal ATP content are presented in Fig. 5. There were no 
significant differences in tissue ATP levels between the intact and treated parts of the 
esophagus in the saline-treated control group. Intraluminal bile and bile + HCI 
resulted in an approximately 40% decrease in esophageal tissue ATP level (bile: 
M=2.66; 25p=2.04; 75p=3.25; bile-HCI: M=2.42; 25p=2.19; 75p=3.05) by the end of 
the observation period. In these groups, the ATP levels were significantly reduced as 
compared with the saline-treated group. Administration of HCI alone did not influence 
the esophageal ATP content (Fig. 5). 
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Figure 5. Tissue ATP contents in the intact 
and treated parts of the esophagus at the 
end of the experiments. Saline-treated 
control group: white box, bile-treated group: 
black box, HCI + bile-treated group: gray box, 
HCI-treated group: hatched box. * p< 0.05 vs. 
baseline, x p<0.05 vs. saline-treated control 
group. 
Tissue samples taken from the intact and saline-treated parts of the 
esophagus of the control group exhibited an average grade of injury of 2.57 (range of 
scores 0-18) (Fig. 6; Fig. 7a). Control samples from the bile, bile + HCI, and HCI-
treated groups revealed the structure of the normal esophageal mucosa. In these 
sections, the luminal surface was lined by a continuous layer of epithelial cells. 
Grading of the e s o p h a g e a l injury 
Lanas s c o r e 
x 
1 
T. 
± 
Saline Bile HCl+bile HCl 
Treated region of the e s o p h a g u s 
Figure 6. Scores of histological evaluation of 
mucosal damage of the esophagus, with 
grading performed according to Lanas et al. 
(see Methods for description). Saline-treated 
control group: white box, bile-treated group: 
black box, HCI + bile-treated group: gray box, 
HCI-treated group: hatched box. x p<0.05 vs. 
saline-treated control group. 
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Semiquantitative evaluation of samples from bile-treated animals revealed a 
significant exacerbation of the mucosal injury in all cases (p < 0.01) and an injury 
score of 62.61 (range 42-90). Moderate and severe lesions were commonly 
observed, with epithelial desquamation and necrosis, intraepithelial and subepithelial 
leukocytosis, basal cell hyperplasia and subepithelial connective tissue damage (Fig. 
7b). 
Figure 7. A : Histological picture of normal esophagus in saline-treated group (group 1). The 
epithelium is essentially of normal thickness. The submucosa, the esophageal glands and the 
muscularis layer show no significant pathological lesions (H & E staining, original magnification 112x). 
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Figure 7. B : Severe damage in group 2 (bile-treated). Extensive epithelial loss (erosion) with 
transmural inflammation, edema and vasodilatation (H & E, original magnification 112x). 
Less severe lesions were observed following bile + HCI treatment (Fig. 7c). In 
this group, mild and moderate lesions were usually seen within the same section. 
Disruption of the epithelial layer, desquamation, minor necrosis, intraepithelial 
leukocytosis, edema of the subepithelial connective tissue and subepithelial 
leukocytosis were generally observed, but the deeper tissue layers were less strongly 
involved. The injury score was 38.66 (range 21-70) (Fig.6). 
In HCI-treated group 4, the reactive epithelial changes were different from 
those observed in the bile alone or bile + HCI-treated groups (Fig. 7d). The injury was 
apparently less severe in this environment (average score 29.7, range 18-42; Fig. 6). 
The subepithelial inflammation was milder, and petechiae were rarely observed. In 
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general, there was no evidence of deep submucosal damage, though transmural 
lesions could occasionally be observed. 
Figure 7. C : Intra- and subepithelial inflammatory cells in group 3 (HCI + bile treated). The 
inflammatory cells in the submucosa are mainly around the esophageal gland ducts (H & E, original 
magnification 112x). 
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Figure 7. D : Mainly epithelial damage displayed in group 4 (HCI-treated). The basal cell 
hyperplasia is considerable, and the subepithelial lesions are negligible (H & E, original 
magnification 112x). 
3.2. STUDY II. 
The baseline values of the macrohemodynamic variables did not differ 
significantly in the different groups and there were no significant hemodynamic 
changes as compared with the baseline values during the experimental period (data 
not shown). In the control group, saline administration did not significantly influence 
the histology scores of the mucosal morphology. 
The baseline level of the capillary RBCV ranged between 430 and 470 pm s"1 
in the various groups. In the control group, the RBCV in the capillaries of the 
esophagus did not change during the experiments. However, the RBCV was 
increased significantly after the 3-h exposure to the bile or HCI-containing test 
solutions and average values of 607, 730 and 620 pm s"1 were measured after bile, 
HCI and bile + HCI treatment, respectively (Figure 8). 
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Figure 8. Effects of various intraluminar 
treatments on the red blood cell velocity 
(RBCV) of the esophageal mucosa (pm s"1). 
Saline treatment (thin line with filled triangles), 
bile treatment (thick line with empty triangles), 
HCI treatment (thin line with empty squares) 
and bile + HCI-treated (thick line with empty 
circles) groups. * p<0.05 within groups vs. 
baseline values; X p<0.05 between groups vs. 
saline-treated control group values. Time (h) 
The RVA was significantly elevated in all treated groups as compared with the 
sham-operated group or with the baseline. Administration of bile, HCI alone or bile + 
HCI resulted in a rise from of the baseline values 0.319, 0.333 and 0.312 to 0.437 
(0.365; 0.473), 0.41 (0.391; 0.442) and 0.425 (0.415; 0.465), respectively (Figure 9). 
RVA 
0.50 -
FCD (pm-1) 
0.40 -
0.30 
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—. — piio+un 
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Figure 9. Changes in the relative vessel area 
(RVA) in the saline-treated (thin line with filled 
triangles), bile-treated (thick line with empty 
triangles), HCI-treated (thin line with empty 
squares) and bile + HCI-treated (thick line with 
empty circles) groups. * p<0.05 within groups vs. 
baseline values; X p<0.05 between groups vs. 
saline-treated control group values. 
Figure 10. Changes in the functional capillary 
density (FCD) values (pm1) in the saline-treated 
(thin line with filled triangles), bile-treated (thick line 
with empty triangles), HCI-treated (thin line with 
empty squares) and bile + HCI-treated (thick line 
with empty circles) groups. * p<0.05 within groups 
vs. baseline values; X p<0.05 between groups vs. 
saline-treated control group values. 
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The FCD was not influenced by luminal bile or HCI + bile treatment for 3 h. 
However, HCI treatment alone was followed by a significant decrease from 0.0377 
prn"1 (0.0342; 0.040) to 0.0292 Mm"1 (0.027; 0.0307) at the end of the experimental 
period (Figure 10). 
The effects of bile, HCI and bile + HCI on the mucosal morphology are 
presented in Figure 11. The structural damage to the mucosa was quantified by 
histology using two different scoring systems; in consequence of the highly 
characteristic tissue lesions, there was no significant difference between the results 
of the evaluation methods. The biopsy samples from the saline-treated control group 
exhibited an average grade of injury of 2.25 (range of scores: 0-18) on the Lanas 
scale, and of 0.37 (range of scores: 0-3) on the Geisinger scale. The 3-h bile 
exposure induced severe mucosal damage, with median values of 65 (range: 50-70) 
on the Lanas scale, and 12 (range 8-14) on the Geisinger scale (p<0.01). Deep 
lesions were commonly observed, with extensive epithelial loss, desquamation and 
necrosis, intraepithelial and subepithelial leukocytosis, basal cell hyperplasia and 
subepithelial connective tissue damage. In most cases, transmural inflammation, 
edema and vasodilatation were apparent. 
Geisinger score Lanas score 
x 
j r . 
Saline Bile 
T 
HCI Bile+HCI 
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h 90 
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h 50 
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Figure 11. Scores of histological 
evaluation of the mucosal damage of 
the esophagus, with grading 
performed according to Lanas et al. 
and Geisinger et al. (see Methods for 
description). Geisinger-score: empty 
column; Lanas score: shaded 
column; The tops of the columns 
show the median values. The capped 
bars indicate the 25th and 75th 
percentiles, respectively. X p<0.05 
between groups vs. saline-treated 
control group values. 
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In HCI-treated group 3, the reactive mucosal changes were different from 
those observed in the bile-treated groups. HCI administration induced severe 
epithelial damage with considerable basal cell hyperplasia. Petechiae and deep 
transmural lesions were only observed occasionally. The median value of the Lanas 
scores was 30 (range 19-40), and that was of the Geisinger scores 5.0 (range 3-7). 
Following treatment with bile + HCI, the histology revealed less severe (mild to 
moderate) morphological changes. Although disruption of the epithelial layer, 
desquamation, intra- and subepithelial inflammatory cells and subepithelial 
connective tissue edema were generally observed, the deeper tissue layers were 
less involved. The degree of injury was 33 (range: 25-50) on the Lanas scale, and 5 
(range: 5-7) on the Geisinger scale. 
The MPO data demonstrated that the leukocyte accumulation was significantly 
increased in the mucosa in groups 2, 3 and 4 as compared with saline-treated group 
1 (Figure 12). Bile, HCI alone or bile + HCI administration resulted in a 10-fold 
(M=50.0; 25p=29.5; 75p=76.1), 3-fold (M=15.0; 25p=11.2; 75p=17.9) and 8-fold 
(M=41.5; 25p=34.3; 75p=49.9) rise in MPO activity, respectively. Although the 
average MPO values were usually higher within the muscle, the MPO activities in the 
two tissue layers were not significantly different. Both bile and bile + HCI 
administration resulted in a 5-fold elevation, while HCI administration alone resulted 
in an approximately 2-fold increase in muscle MPO activity (Figure 12). 
Figure 12. Myeloperoxidase (MPO) 
activity in the mucosa (empty 
column) and the muscle tissue 
(shaded column) of the esophagus 
180 min after treatment. The tops of 
the columns show the median values. 
The capped bars indicate the 25th and 
75th percentiles, respectively. X 
p<0.05 between groups vs. saline-
treated control group values. 
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Figure 13 depicts the changes in the esophageal cNOS and iNOS activities. 
The activity of cNOS was significantly depressed after bile treatment, and this 
change was accompanied by a significant, approximately 5-fold increase in iNOS 
activity. HCI treatment did not influence the esophageal cNOS activity, while it 
resulted in a somewhat lower, 2.5-fold increase in iNOS activity, as compared with 
the value for the sham-operated group. Similarly, the cNOS activity was not 
influenced by bile + HCI administration for 3 hours, whereas the activity of iNOS was 
increased significantly, similarly as observed after bile treatment alone. 
NOS activity (fmol (mg protein)"' min'1) 
iNOS 
Saline Bile HCI Bile+HCI 
Figure 13. Changes in constitutive 
(empty column) and inducible 
(shaded column) NOS activities (fmol 
(mg protein)"1 min"1) in esophageal 
tissue from saline-treated (n=5), bile-
treated (n=8), HCI-treated (n=5) and 
bile + HCI-treated (n=5) animals. The 
tops of the columns show the median 
values. The capped bars indicate the 
25th and 75th percentiles, respectively. 
X p<0.05 between groups vs. saline-
treated control group values. 
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4. DISCUSSION 
Despite the continuously growing body of information, the exact 
pathophysiology of the reflux-induced mucosal dysfunction leading to clinico-
pathologic complications is still unknown. The importance of duodenal components in 
the progression of GERD is well known, in recent decades duodenogastro-
esophageal reflux or alkaline reflux has become an autonomic entity (Vaezi et al., 
2001). In a number of cases, the bile content of the regurgitated fluid has been 
demonstrated by a fiberoptic probe (Bilitec) in the esophagus, and it has been 
confirmed that a mixed reflux is more harmful than gastric juice alone (Stein et al., 
1999, Kauer et al., 1995). 
Our in vivo study has provided a comparison of the separate responses to HCI 
and bile in the canine esophagus. The results reveal that intraluminal bile may be 
involved in the mechanism of esophageal ATP reduction and mucosal impairment 
barrier simultaneously. Bile and HCI mixed together decreased the ATP content of 
the exposed tissues, increased the epithelial and vascular permeability indices, 
evoked a rise in leukocyte accumulation, and induced severe structural alterations in 
the esophageal mucosa. The reduction in the mucosal ATP level was attributed 
exclusively to bile. 
Bile acid toxicity has been repeatedly demonstrated in the hepatic tissues. It 
has recently been confirmed that the intrahepatic accumulation of toxic bile salts is 
directly connected with a mitochondrial dysfunction (Schmucker et al., 1990, 
Krahenbuhl et al., 1994). Similarly, it has been shown that bile salts cause 
hepatocyte death by inducing mitochondrial permeability transition, Fas-dependent 
hepatocyte apoptosis or necrosis. Bile salts at low concentrations inhibit the activities 
of complexes I and III of the mitochondrial respiratory chain (Rosser et al., 1995). 
Although the disturbance of mitochondrial energy production could be an important 
factor in the pathomechanism of acute damage of the canine esophagus, the 
sequence of events is still unclear. Bile-induced ATP depletion may be an important 
component of the esophageal damage, but the different sensitivities of the 
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esophageal and intestinal mucosal surfaces toward bile remains an interesting 
problem. Moreover, nonspecific detergent effects of bile, such as bile-induced 
oxidative damage, have to be considered. 
At first sight, a biliary reflux alone can not evolve in GERD patients. However, 
HCI secretion can be completely blocked by novel proton pump inhibitor therapy. 
With long-term continuous proton pump inhibitor therapy, HCI suppression results in 
a pH > 5.0 and "iatrogenic bile reflux" may occur if a duodenogastro-esophageal 
reflux is also present. Further, achlorhydria or gastric acid suppressive therapy might 
lead to bacterial colonization in the upper gastrointestinal tract (Drasar et al., 1969). 
As a result of the bacterial flora, deconjugated bile acids appear in a higher 
proportion, inducing severe mucosal damage in the esophagus (Salo et al., 1983). 
Thus, in patients on proton pump therapy with concomitant bile regurgitation, a "bile 
danger zone" of higher pH (pH > 5.0) has to be considered. 
The link between gastric pH and esophageal injury has been the source of 
controversy. Previous studies have demonstrated a synergistic effect of pepsin and 
acid in mucosal damage at low pH; and these results have led the authors to suggest 
that gastric acid exerts an indirect effect on esophageal damage by determining 
peptic activity (Dent et al., 1994). However, it has recently been shown that the 
presence of pepsin did not exacerbate the severity of acid-induced esophageal injury 
(Pursnani et al., 1998). Similarly, it is important to note that the solubility of bile salts 
may be dependent on luminal pH (Goldstein et al., 1990). Although the importance of 
this phenomenon remains to be investigated, it seems that in our study the degree of 
bile induced mucosal injury was not influenced by pH. 
In line with these data, there is good evidence that a 4-h bile exposure results 
in a process which significantly affects the permeability characteristics of the canine 
esophagus. The falling level of tissue ATP described here was accompanied by an 
increased mucosal permeability in the blood-to-lumen and lumen-to-blood directions, 
and by a significant decrease in transmucosal potential difference. The transmucosal 
potential difference maintained across the healthy mucosa is thought to be due to 
asymmetric ion pumping combined with resistance to the back-diffusion of the 
separated charge (Racz et al., 1988). A decreased transmucosal potential difference 
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is indicative of a loss of mucosal integrity and also points to a disturbed mitochondrial 
energy turnover (Scarpignato et ai, 1995). The degree of impairment of the 
protective mucosal barrier may range from reversible permeability changes to 
complete transmural necrosis. The extent of permeation across the mucosal barrier 
depends on the solubility and size of the molecule and on the blood flow. 
Equilibration of small molecules such as NaFI requires only a short period, and subtle 
structural changes might therefore result in rapid permeation changes in the mucosa. 
Although the overall results of our study suggest that the permeability alterations in 
the esophageal mucosa may be dependent on bile-induced ATP depletion, this 
possibility should be treated with caution. It is clear that the early mucosal responses 
to luminal damaging agents involve a multiplicity of factors, and the mechanism of 
chronic bile salt-induced mucosal dysfunction remains an area of active 
investigations. However, it is tempting to speculate that bile salts may play similar 
triggering roles in GERD after prolonged or intermittent bile exposure. 
In our model, exposure to either HCI or bile was accompanied by a significant 
rise in tissue MPO activity. The contact of the neutrophil leukocyte with a 
chemoattractant triggers a complex metabolic event, with the production of oxygen 
intermediates. Once the leukocytes have entered the tissues, they might induce 
further endothelial and epithelial damage and interfere with the aggressive action of 
intraluminal agents. Although these data suggest that reflux-induced leukocyte 
activation and tissue accumulation might be secondary components of the 
pathomechanism of mucosal destruction, more direct approaches are needed to 
identify the roles of bile and HCI precisely in the microvascular changes and 
leukocyte reactions. In this regard, our results emphasize the importance of 
monitoring functional parameters of esophageal injuries in order to obtain valid 
conclusions from studies involving tissue salvage therapies. 
It has been found that the intraluminal administration of HCI induces increases 
in esophageal permeability and MPO activity with the same efficacy as observed for 
HCI mixed with bile or bile alone. Similarly, the evolved injury of the esophageal 
mucosa could be directly connected to the "topical" effect of HCI. On the other hand, 
exogenous HCI had no effect on the mucosal ATP content. It is therefore conceivable 
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that a synergy exists between the two components, and biliary reflux may play a key 
role in the HCI-induced loss in mucosal integrity or significantly exacerbate the 
manifestation of structural mucosal damage. 
Study II showed that the early microcirculatory consequences of biliary 
exposure appear quickly after the start of the treatment. The RBCV and the RVA 
were significantly increased at 90 min, while the FCD was unchanged until 180 min. 
The RBCV is determined primarily by the blood flow and the cross-section of the 
circulatory area and this suggests that significant vasodilation evolves in the mucosa. 
The MPO data implied that leukocytes accumulated in the mucosa, and the enzyme 
activity was very high in the muscle layer too. The histology also revealed the 
destructive effects of bile: in almost all cases, a deep, almost transmural injury was 
observed. These data together demonstrate that the noxious agent penetrates very 
deep into the esophageal wall. 
NO, formed in vivo by the continuously active cNOS, is involved in the 
physiological regulation of the peripheral vascular tone (Moncada et al., 1991). In 
inflammation, endotoxemia or sepsis, a distinct isoform, the inducible, Ca2+-
independent iNOS is activated, thereby leading to an excessive production of NO 
(Zhang et al., 1998). In our study, the bile-induced microcirculatory alterations were 
accompanied by inverse changes in cNOS and iNOS activities. Previously, we have 
shown that the multifactorial ulcer-producing actions of bile are initiated by the 
lowering the ATP generation in the affected esophageal tissues. Although the 
disturbance of mitochondrial energy production could be an important factor in the 
acute decrease in cNOS activity in the canine esophagus, the molecular mechanism 
of the events is still unclear. 
The effects of bile on the cNOS activity have been described in biliary fibrosis 
(Zimmermann et al., 1996) and after experimental bile-duct ligation (Wei et al., 2002 
Rockey et al., 1998). Recently, it has also been reported that a low cNOS and an 
increased iNOS activity are responsible for the exacerbation of gastric injury from 
luminal irritants during endotoxemia (Helmer et al., 2002). The increased iNOS 
activity could be a compensatory phenomenon of cNOS inhibition or an aftermath of 
inflammatory stimuli. It should be noted that a proposed cause of carcinogenesis in 
GERD is chronic inflammation (Fein et a!., 2000), while others suggested that the 
mechanism of the mitogenic effects of bile acids may involve the N-nitrosation of 
glycine and taurine amides, leading to the production of carcinogenic N-nitroso 
amides (Dayal et al, 1997). Because of its short half-life, the effects of NO are limited 
to the site of its production; thus, NO-related vascular changes mostly depend on 
local NO synthesis. NO plays a central role in the maintenance of the normal resting 
esophageal mucosal blood flow, and an increased esophageal blood flow may be a 
protective response against damaging gastric juice or other noxious stimuli (McKie et 
al., 1995, Sandler et al., 1993). Similarly, the rapid induction of iNOS may in the short 
run protect the tissue against microbial infection. However, excess NO generation in 
the inflamed tissue is likely to lead directly to the formation of N-nitroso compounds, 
and it is tempting to speculate that the bile-induced overproduction of NO through the 
activation of iNOS may in the long run play a role in the mutagenic process (Bartsch 
et al., 1992). 
HCI induced a more superficial injury as compared with bile, and the intensity 
and extent of leukocyte accumulation were also somewhat more moderate. The 
consequence of HCI exposure on the microcirculation were different too. Vasodilation 
and an increased flow rate were again present, but concomitantly the FCD was 
decreased. It has been reported that the adaptive increase in flow after HCI treatment 
is dependent on the paracrine effect of NO, but mast cell-derived histamine, 
substance P and calcitonin gene-related peptide, also play roles in this response 
(Sandler et al., 1993, Feldman et al., 1996, Feldman et al., 2001). The acute 
reduction in the FCD is usually due to an imbalance in the Starling forces or 
intravascular cellular events influencing the circulation in the subepithelial capillary 
network. A decreased FCD is a characteristic of low-flow ischemia, but this condition 
is regularly observed with blood acidosis in both hemorrhagic shock and intentional 
acid infusion (Mazzoni etal., 1995). 
It is important that the instillation of HCI did not change the cNOS activity, 
which suggests that the increase in iNOS activity is a consequence of a separate, 
secondary inflammatory reaction. Although the amount of bioavailable NO is usually 
unknown, it has been shown that the iNOS mRNA expression increases within 30 
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min after an inflammatory challenge, and this is followed several hours later by 
increased plasma levels of the NO metabolites nitrate and nitrite (Bateson et al., 
1996). 
It seems that the mixture of HCI and bile induced an intermediate condition. 
The alkaline pH improved the microcirculatory consequences of the acid-induced 
damage the FCD did not change, and the detrimental effects of the bile were also 
mitigated as the cNOS activity was not inhibited in this case. It was recently 
suggested that HCI-suppressive therapy in GERD patients increases the stomach pH 
and that this will remove the charges on the conjugated bile acids, allowing entry into 
the epithelium (Stamp et al., 2002). Our results strengthen this hypothesis and 
suggest that the reactive response of the esophageal mucosa to a pure biliary reflux 
is indeed alleviated in the presence of gastric acid. 
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5. SUMMARY 
Our animal model provides a useful protocol to investigate the 
pathophysiological and morphological consequences of acute gastroesophageal 
regurgitation. The dissected esophagus portion was fit for the insertion the different 
instruments, probes, cannulas, etc. We have demonstrated that bile induces ATP 
depletion, contributes to the early mucosal permeability alterations and barrier 
lesions during experimental reflux, and plays an important role in intramucosal 
leukocyte accumulation and structural injury. Our data suggest that severe bile-
induced tissue injury may evolve when the pH of the refluxed material is 6.0 or 
above. Our experimental model allowed the first in vivo visualization of the canine 
esophageal microcirculation. Bile impairs the cNOS activity and enhances the iNOS 
activity, and may therefore induce NO overproduction-related changes in the later 
phases of reflux. Medical therapy usually does not stop bile from regurgitating to the 
esophagus, and acid suppression is often incomplete (Peghini 1998). While acid 
suppressive therapy remains a cornerstone of treatment for GERD, the deleterious 
consequences of biliary exposure on esophageal mucosal NO synthesis could be 
manifested in the absence of acid. Although the extrapolation of findings of animal 
studies to humans could be difficult, the results underline the significance of bile in 
the pathogenesis of mucosal injury of GERD. 
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8. Abbreviations 
GERD: Gastroesophageal reflux disease 
LES: Lower esophageal sphincter 
NO: Nitric oxide 
cNOS: Constitutive nitric oxide synthase 
iNOS: Inducible nitric oxide synthase 
MAP: Mean arterial pressure 
NaFI: Sodium fluorescein 
ATP: Adenosine triphosphate 
MPO: Myeloperoxidase 
HCI: Hydrochloric acid 
OPS: Orthogonal polarization spectral 
FCD: Functional capillary density 
RVA: Relative vessel area 
RBCV: Red blood cell velocity 
H&E: Hematoxylin-eosin 
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9. ANNEX 
